Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (301-310 of 350) with videos related to

Pageof 35
Sort By:
Nature Communications|July 27, 2023
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomasRomain Sigaud, Thomas K Albert, Caroline Hess, et al.
Blood Advances|April 23, 2026
DNA methylation-based classification of hematolymphoid neoplasmsAnnapurna Saksena, Christin Siewert, Rust Turakulov, et al.
Neuro-Oncology|January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutantEmilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Acta Neuropathologica Communications|January 11, 2022
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survivalAzadeh Ebrahimi, Andrey Korshunov, Guido Reifenberger, et al.
Acta Neuropathologica|August 11, 2018
Correction to: DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Neuro-Oncology|April 19, 2023
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patientsEmily C Hardin, Simone Schmid, Alexander Sommerkamp, et al.
Acta Neuropathologica|February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCAYanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
A prospective observational study of real-world treatment and outcome in secondary CNS lymphomaStefan Habringer, Uta M Demel, Anne-Katrin Fietz, et al.
Acta Neuropathologica|October 22, 2022
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1Patrick J Cimino, Courtney Ketchum, Rust Turakulov, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Pageof 35

Showing results (301-310 of 350) with videos related to

Sort By:
Pageof 35
Nature Communications|July 27, 2023
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomasRomain Sigaud, Thomas K Albert, Caroline Hess, et al.
Blood Advances|April 23, 2026
DNA methylation-based classification of hematolymphoid neoplasmsAnnapurna Saksena, Christin Siewert, Rust Turakulov, et al.
Neuro-Oncology|January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutantEmilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Acta Neuropathologica Communications|January 11, 2022
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survivalAzadeh Ebrahimi, Andrey Korshunov, Guido Reifenberger, et al.
Acta Neuropathologica|August 11, 2018
Correction to: DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Neuro-Oncology|April 19, 2023
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patientsEmily C Hardin, Simone Schmid, Alexander Sommerkamp, et al.
Acta Neuropathologica|February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCAYanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
A prospective observational study of real-world treatment and outcome in secondary CNS lymphomaStefan Habringer, Uta M Demel, Anne-Katrin Fietz, et al.
Acta Neuropathologica|October 22, 2022
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1Patrick J Cimino, Courtney Ketchum, Rust Turakulov, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Pageof 35